Table 1 Patient demographics and hemodynamic responses to regadenoson
| Â | Aminophylline | No aminophylline | P value |
|---|---|---|---|
(n = 10) | (n = 10) | ||
Age (yr) | 32 (7) | 32 (13) | 0.90 |
% female | 70 | 50 | 0.65 |
% Caucasian | 70 | 50 | 0.65 |
LVEF (%) | 61 (5) | 61 (5) | 0.97 |
LVEDV index (mL/m 2 ) | 85 (9) | 84 (14) | 0.89 |
Baseline HR (BPM) | 68 (9) | 65 (14) | 0.67 |
HR change, baseline to stress (BPM) | +55 (11) | +48 (13) | 0.22 |
HR change, stress to recovery (BPM) | −48 (11) | −35 (12) | 0.03 |
HR change, rest to recovery (BPM) | +7 (9) | +13 (12) | 0.24 |
Baseline MAP (mmHg) | 77 (11) | 78 (12) | 0.75 |
Change in MAP, baseline to stress (mmHg) | +3 (10) | +4 (7) | 0.81 |